Evidence map›Paper›PMID 35223351›Full record

ReviewBeilstein journal of nanotechnology2022

Engineered titania nanomaterials in advanced clinical applications.

Padmavati Sahare, Paulina Govea Alvarez, Juan Manual Sanchez Yanez, Juan Gabriel Luna Bárcenas, Samik Chakraborty, Sujay Paul, Miriam Estevez

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Beilstein journal of nanotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Padmavati SahareCentre of Applied Physics and Advanced Technologies (CFATA), National Autonomous University of Mexico, Queretaro, Mexico.ORCID https://orcid.org/0000-0002-5052-4019
Paulina Govea AlvarezCentre of Applied Physics and Advanced Technologies (CFATA), National Autonomous University of Mexico, Queretaro, Mexico.ORCID https://orcid.org/0000-0002-1366-6640
Juan Manual Sanchez YanezInstituto de Investigaciones Químico Biológicas, Universidad Michoacana de San Nicolas de Hidalgo, Morelia, Mexico.
Juan Gabriel Luna BárcenasGrupo de Investigación de Biomateriales, Ciencia de los Materiales, Cinvestav, Querétaro, Mexico.
Samik ChakrabortyDivision of Nephrology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Sujay PaulTecnologico de Monterrey, School of Engineering and Sciences, Campus Queretaro, Av. Epigmenio Gonzalez, No. 500 Fracc. San Pablo, CP 76130 Querétaro, Mexico.ORCID https://orcid.org/0000-0001-5024-7261
Miriam EstevezCentre of Applied Physics and Advanced Technologies (CFATA), National Autonomous University of Mexico, Queretaro, Mexico.ORCID https://orcid.org/0000-0003-4749-7715

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Significant advancement in the field of nanotechnology has raised the possibility of applying potent engineered biocompatible nanomaterials within biological systems for theranostic purposes. Titanium dioxide (titanium(IV) oxide/titania/TiO

Indexed as

clinical applicationnanostructuresphysicochemicaltheranosticstitanium dioxide (TiO2)

Identifiers

PMID35223351
PMCPMC8848344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.